BIOLASE (BIOLQ)
OTHER OTC:BIOLQ
US Market
Holding BIOLQ?
Track your performance easily

BIOLASE (BIOLQ) Financial Statements

1,635 Followers

BIOLASE Financial Overview

BIOLASE's market cap is currently ―. The company's EPS TTM is $-7.846; its P/E ratio is >-0.01; BIOLASE is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Mar 23
Income Statement-
Total Revenue$ 10.85M$ 11.55M$ 10.13M$ 10.92M$ 10.47M
Gross Profit$ 4.38M$ 4.61M$ 3.34M$ 3.75M$ 3.34M
EBIT$ -816.00K$ -2.18M$ -5.87M$ -3.98M$ -5.85M
EBITDA$ -54.00K$ -1.41M$ -5.08M$ -3.42M$ -5.59M
Net Income Common Stockholders$ -1.36M$ -2.80M$ -6.49M$ -4.59M$ -5.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.44M$ 5.27M$ 6.39M$ 7.81M$ 6.50M
Total Assets$ 27.24M$ 30.64M$ 34.35M$ 38.74M$ 41.95M
Total Debt$ 16.25M$ 13.74M$ 14.55M$ 15.10M$ 15.33M
Net Debt$ 12.81M$ 8.47M$ 8.16M$ 7.29M$ 8.83M
Total Liabilities$ 32.12M$ 32.77M$ 34.08M$ 32.86M$ 33.79M
Stockholders Equity$ -5.23M$ -3.98M$ -1.93M$ 332.00K$ 8.16M
Cash Flow-
Free Cash Flow$ -4.44M$ -674.00K$ -5.74M$ -2.77M$ -6.25M
Operating Cash Flow$ -4.47M$ -734.00K$ -5.94M$ -2.59M$ -5.66M
Investing Cash Flow$ 34.00K$ 60.00K$ 197.00K$ -182.00K$ -587.00K
Financing Cash Flow$ 2.49M$ -428.00K$ 5.65M$ 3.76M$ 8.52M
Currency in USD

BIOLASE Earnings and Revenue History

BIOLASE Debt to Assets

BIOLASE Cash Flow

BIOLASE Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis